Racial factors play a significant role in SSc. We evaluated differences in SSc presentations between white patients (WP), Asian patients (AP) and black patients (BP) and analysed the effects of geographical locations. Methods: SSc characteristics of patients from the EUSTAR cohort were cross-sectionally compared across racial groups using survival and multiple logistic regression analyses. Results: The study included 9162 WP, 341 AP and 181 BP. AP developed the first non-RP feature faster than WP but slower than BP. AP were less frequently anti-centromere (ACA; odds ratio (OR) = 0.4, P < 0.001) and more frequently anti-topoisomerase-I autoantibodies (ATA) positive (OR = 1.2, P = 0.068), while BP were less likely to be ACA and ATA positive than were WP [OR(ACA) = 0.3, P < 0.001; OR(ATA) = 0.5, P = 0.020]. AP had less often (OR = 0.7, P = 0.06) and BP more often (OR = 2.7, P < 0.001) diffuse skin involvement than had WP. AP and BP were more likely to have pulmonary hypertension [OR(AP) = 2.6, P < 0.001; OR(BP) = 2.7, P = 0.03 vs WP] and a reduced forced vital capacity [OR(AP) = 2.5, P < 0.001; OR(BP) = 2.4, P < 0.004] than were WP. AP more often had an impaired diffusing capacity of the lung than had BP and WP [OR(AP vs BP) = 1.9, P = 0.038; OR(AP vs WP) = 2.4, P < 0.001]. After RP onset, AP and BP had a higher hazard to die than had WP [hazard ratio (HR) (AP) = 1.6, P = 0.011; HR(BP) = 2.1, P < 0.001]. Conclusion: Compared with WP, and mostly independent of geographical location, AP have a faster and earlier disease onset with high prevalences of ATA, pulmonary hypertension and forced vital capacity impairment and higher mortality. BP had the fastest disease onset, a high prevalence of diffuse skin involvement and nominally the highest mortality.

Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study / V.K. Jaeger, M. Tikly, D. Xu, E. Siegert, E. Hachulla, P. Airo, G. Valentini, M.M. Cerinic, O. Distler, F. Cozzi, P. Carreira, Y. Allanore, U. Muller-Ladner, L.P. Ananieva, A. Balbir-Gurman, J.H.W. Distler, L. Czirjak, M. Li, J. Henes, S.A. Jimenez, V. Smith, N. Damjanov, C.P. Denton, F. Delgaldo, L.A. Saketkoo, S.B. Randone, B. Bannert, F. Iannone, B. Maurer, S. Jordan, R. Dobrota, M. Becker, C. Mihai, R. Becvarare, M. Tomcik, O.K. Bielecka, E. Gindzienska-Sieskiewicz, K. Karaszewska, M. Cutolo, C. Pizzorni, S. Paolino, A. Sulli, B. Ruaro, E. Alessandri, A. Riccardi, V. Giacco, V. Messitini, R. Irace, C. Kedor, V. Casteleyn, J. Hilger, J. Hoeppner, S. Rednic, I. Szabo, A. Petcu, J. Avouac, F. Camelia, C. Desbas, P. Vlachoyiannopoulos, C.M. Montecucco, R. Caporali, L. Cavagna, J. Stork, M. Inanc, B.E. Joven, S. Novak, F. Anic, C. Varju, T. Minier, C. Chizzolini, D. Allai, E.J. Kucharz, A. Kotulska, M. Kopec-Medrek, M. Widuchowska, A.S. Dolnicar, B. Coleiro, A. Gabrielli, L. Manfredi, D. Benfaremo, A. Ferrarini, D.F. Bancel, A. Hij, M.G. Lazzaroni, R. Hesselstrand, D. Wuttge, K. Andreasson, D. Martinovic, I. Bozic, M. Radic, Y. Braun-Moscovici, A.L. Monaco, F. Furini, N. Hunzelmann, P. Moinzadeh, R. Pellerito, C. Caimmi, E. Bertoldo, J. Morovic-Vergles, I.M. Culo, A.-. Pecher, V.O. Santamaria, S. Heitmann, M. Codagnone, J. Pflugfelder, D. Krasowska, M. Michalska-Jakubus, M. Seidel, P. Hasler, S. Kretschmar, M. Kohm, G. Bajocchi, M.J. Salvador, J.P. Da Silva, B. Stamenkovic, A. Stankovic, C.F. Selmi, M. De Santis, A. Ceribelli, L. Garzanova, O. Koneva, M. Starovoytova, A. Herrick, F. Puppo, S. Negrini, G. Murdaca, M. Engelhart, G. Szucs, S. Szamosi, C. De La Puente, C.S. Grande, M.J.G. Villanueva, O. Midtvedt, A.-. Hoffmann-Vold, D. Launay, V. Sobanski, V. Riccieri, M. Vasile, K. Stefantoni, R.M. Ionescu, D. Opris, A. Sha, A. Woods, A.M. Gheorghiu, M. Bojinca, C. Sunderkotter, J. Ehrchen, F. Ingegnoli, L. Mouthon, B. Dunogue, B. Chaigne, P. Legendre, F.P. Cantatore, A. Corrado, S. Ullman, L. Iversen, C.A. Von Muhlen, M.R. Pozzi, K. Eyerich, F. Lauffer, P. Wiland, M. Szmyrka-Kaczmarek, R. Sokolik, E. Morgiel, M. Madej, M. Vanthuyne, H. Frederic, J.J. Alegre-Sancho, M. Aringer, K. Herrmann, C. Gunther, R. Westhovens, E. De Langhe, J. Lenaerts, B. Anic, M. Baresic, M. Mayer, M. Uprus, K. Otsa, S. Yavuz, B. Granel, S.C. Radominski, C. De Souza Muller, V. Feijoazevedo, F. Mendoza, J. Busquets, S. Popa, S. Agachi, T. Zenone, M. Pileckyte, S. Stebbings, S. Jordan, A. Mathieu, A. Vacca, P.D. Sampaio-Barros, L. Stamp, K. Solanki, C. Silva, J. Schollum, H. Barns-Graham, D. Veale, M. O'Rourke, E. Loyo, C. Tineo, G. Paulino, W.A.A.A. Mohamed, E. Rosato, A. Gigante, F. Oksel, F. Yargucu, C.-. Tanaseanu, M. Popescu, A. Dumitrascu, I. Tiglea, R. Foti, E. Visalli, A. Benenati, G. Amato, C. Ancuta, P. Villiger, S. Adler, J. Frohlich, C. Kayser, A.L. Eduardo, N. Fathi, S. Alii, M. Ahmed, S. Hasaneen, E. El Hakeem, P.G. De La Pena Lefebvre, J.J.G. Martin, J. Sibilia, E. Chatelus, J.E. Gottenberg, H. Chifflot, I. Litinsky, F. Del Galdo, G. Abignano, S. Eng, G. Seskute, I. Butrimiene, R. Rugiene, D. Karpec, M. Pascal, E. Kerzberg, W. Bianchi, B.V. Bianchi, D.V. Bianchi, Y. Barcellos, I. Castellvi, M. Millan, M. Limonta, D. Rimar, I. Rosner, G. Slobodin, M. Couto, F. Spertini, C. Ribi, G. Buss, A. Marcoccia, F. Bondanini, A. Ciani, S. Kahl, V.M. Hsu, T. Martin, V. Poindron, K. Meghit, S. Moiseev, P. Novikov, L. Chung, K. Kolstad, M. Stark, T. Schmeiser, A. Thiele, D. Majewski, Z. Zdrojewski, S. Zaneta, K. Wierzba, J. Martinez-Barrio, F.J. Lopez-Longo, V. Bernardino, M.F. Moraes-Fontes, A.C. Rodrigues, G. Riemekasten, S. Sommerlatte, S. Jendreck, S. Arnold, Y. Levy, E. Rezus, A. Cardoneanu, A.M. Burlui, O.N. Pamuk, P.S. Puttini, R. Talotta, S. Bongiovanni, H. Poormoghim, E. Andalib, S. Almasi, I. Kotter, M. Krusche, G. Cuomo, F. Danzo, F. Masini, F. Gaches, M. Michaud, F. Cartos, L. Belloli, C. Casu, P. Sfikakis, M. Tektonidou, D. Furst, G.R. Feldman, A.-. Ramazan, E. Nurmambet, A. Miroto, C. Suta, I. Andronache, T.W.J. Huizinga, J. De Vries-Bouwstra, U.A. Walker. - In: RHEUMATOLOGY. - ISSN 1462-0324. - 59:7(2020), pp. 1684-1694. [10.1093/rheumatology/kez486]

Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study

R. Caporali;F. Ingegnoli;
2020

Abstract

Racial factors play a significant role in SSc. We evaluated differences in SSc presentations between white patients (WP), Asian patients (AP) and black patients (BP) and analysed the effects of geographical locations. Methods: SSc characteristics of patients from the EUSTAR cohort were cross-sectionally compared across racial groups using survival and multiple logistic regression analyses. Results: The study included 9162 WP, 341 AP and 181 BP. AP developed the first non-RP feature faster than WP but slower than BP. AP were less frequently anti-centromere (ACA; odds ratio (OR) = 0.4, P < 0.001) and more frequently anti-topoisomerase-I autoantibodies (ATA) positive (OR = 1.2, P = 0.068), while BP were less likely to be ACA and ATA positive than were WP [OR(ACA) = 0.3, P < 0.001; OR(ATA) = 0.5, P = 0.020]. AP had less often (OR = 0.7, P = 0.06) and BP more often (OR = 2.7, P < 0.001) diffuse skin involvement than had WP. AP and BP were more likely to have pulmonary hypertension [OR(AP) = 2.6, P < 0.001; OR(BP) = 2.7, P = 0.03 vs WP] and a reduced forced vital capacity [OR(AP) = 2.5, P < 0.001; OR(BP) = 2.4, P < 0.004] than were WP. AP more often had an impaired diffusing capacity of the lung than had BP and WP [OR(AP vs BP) = 1.9, P = 0.038; OR(AP vs WP) = 2.4, P < 0.001]. After RP onset, AP and BP had a higher hazard to die than had WP [hazard ratio (HR) (AP) = 1.6, P = 0.011; HR(BP) = 2.1, P < 0.001]. Conclusion: Compared with WP, and mostly independent of geographical location, AP have a faster and earlier disease onset with high prevalences of ATA, pulmonary hypertension and forced vital capacity impairment and higher mortality. BP had the fastest disease onset, a high prevalence of diffuse skin involvement and nominally the highest mortality.
organ manifestations; races; systemic sclerosis; Adult; Aged; Asians; Autoantibodies; Blacks; DNA Topoisomerases, Type I; Female; Humans; Hypertension, Pulmonary; Lung; Male; Middle Aged; Scleroderma, Systemic; Whites
Settore MED/16 - Reumatologia
2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
Racial differences in systemic sclerosis disease presentation.pdf

accesso riservato

Descrizione: Original Article
Tipologia: Publisher's version/PDF
Dimensione 616.7 kB
Formato Adobe PDF
616.7 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/928037
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 58
  • ???jsp.display-item.citation.isi??? 51
  • OpenAlex ND
social impact